Spine surgeon Daniel Park, MD, completed the first U.S. case using Kuros Biosciences’ MagnetOs minimally invasive surgery delivery system, according to an Aug. 5 news release.
MagnetOs MIS, a bone graft delivery system, was cleared by the FDA in May. Compared to a traditional funnel-based system, Magnet OS MIS completed graft placement three times faster.
“MagnetOs MIS delivered smooth, precise graft placement in a typically challenging MIS TLIF case — no preparation, no thawing, just immediate delivery and efficiency,” Dr. Park said in the release. “It pairs streamlined handling with compelling clinical data, making it a meaningful advancement for surgeons who value both efficiency and biologically robust healing.”
A full commercial release is expected for the Fall.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
